IamCurious said...
For example none of the biologic drugs are available as a generic version
This is no longer true. Inflectra is a biosimilar for Remicade, which is the closest thing to a generic available for biologic, and about
20% cheaper. People here have reported getting Inflectra infusions.
EU has a number of biosimilars available for all of the tnf-alpha-blockers and prices have been falling accordingly with competition among generics. A lot more of this will come there, and hopefully here, as well over the coming years.
Here's the FDA list of approved biosimilars USA:
Humira® (biosimilars adalimumab-atto/Amjevita, adalimumab-adbm/Cyltezo, adalimumab-adaz/Hyrimoz)
Remicade® (biosimilars infliximab-dyyb/Inflectra, infliximab-qbtx/Ixifi, infliximab-abda/Renflexis)
Not sure on availability of the others beyond Inflectra, but I expect to hear more about
them this year by posters here!